Study Shows Methyl B12 Benefit in Autism
Injectable methylcobalamin has been shown to improve the clinical status of patients through enhanced cell oxidative status and/or methylation capacity. In this study (2022), the efficiency of a carefully developed syrup form of methylcobalamin was used as a treatment for autism.
Methylcobalamin was administered daily at 500 µg (.5 mg) dose to 25 autistic children and young adults during a 200-day period with positive results. A link to the full report is included below.
